Skip to main content
OpenTrials
Completed

NCT Number: NCT04013061

Impact of a Pharmacist-anesthesiologist Collaboration During Anesthesia Consultation on Prevention of Perioperative Medication Errors of Patients in Programmed Surgery

The investigators will evaluate the efficiency of a pharmacist-anesthesiologist collaboration in the anesthetic consultation in the prevention of medical errors perioperatively in patients undergoing scheduled surgery

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Surgical Procedures, Operative

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU de Montpellier, Montpellier, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The patient must have given their free and informed consent
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient has at least one chronic medication prescription (associated with a chronic illness)
  • The patient is hospitalized for a programmed surgery in the service of urology or digestive surgery at the CHU Nimes or orthopedic surgery in the CHU Montpellier or Toulouse

Exclusion criteria

  • The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • The patient is having ambulatory programmed surgery
  • The patient has an anesthetic consultation in a different health establishment

Treatment and study plan

Pluridisciplinary consultation

Other

Pharmacist-anesthesiologist team will be present during the anesthetic consultation

Primary outcomes

  1. Rate of patients with at least one medication error for chronic treatment

    Time frame: 48 hours post-admission

    %

Secondary outcomes

  1. Nature of medication error

    Time frame: 48 hours post-admission

    According to REMED (Revue des Erreurs liées aux Médicaments Et Dispositifs médicaux) classification

  2. Rate of medication errors corrected

    Time frame: 48 hours post-admission

    %

  3. Rate of prescriptions respecting the Société Française d'Anesthésie et de Réanimation recommendations

    Time frame: 48 hours post-admission

    %

  4. Rate of corrected medication errors or major, critical or catastrophic severity according to HAS 2018

    Time frame: 48 hours post-admission

    %

  5. Rate of patients whose usually prescribed medication at admission is not available for them in the evening following surgery

    Time frame: 48 hours post-admission

    %

  6. Rate of medications not available on the establishment's therapeutic book and not brought by the patient

    Time frame: 48 hours post-admission

    %

  7. Duration in hospital

    Time frame: End of hospitalization (max 30 days)

    Days

  8. Rate of delay or cancellation of surgery linked to preoperational medication error

    Time frame: End of study (13 months)

    %

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Acronym: PREVEMCA

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Jul 9, 2019
Registry last updated
Dec 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.